People with migraines can be instructed to self-administer pulses (single-pulse transcranial magnetic stimulation or sTMS) with the device to treat migraine attacks as needed, finds a new study.
Highlights
- Spring TMS which stands for Spring transcranial magnetic stimulation or sTMS can help treat acute migraine attacks.
- This device showed positive results when participants self administered four pulses two times a day. It even reduced the frequency of headache days by about three days per month. //
- sTMS device is safe, noninvasive and easy to use when comes to acute migraine attacks which are usually very severe.
"Our study demonstrated that the four pulses emitted from this device twice daily reduce the frequency of headache days by about three days per month, and 46 percent of patients had at least 50 percent or fewer migraine attacks per month on the treatment protocol. This data is clinically significant. Based on the current study and prior studies in acute migraine attack treatment, sTMS not only helps to stop a migraine attack, but it also helps prevent them." says Amaal Starling, a neurologist, who is the first author of the study.
"For certain patients, treatment options for migraines, such as oral medications, are not effective, well-tolerated or preferred," Dr. Starling adds. "The sTMS may be a great option for these patients and allow doctors to better meet their unique needs.”
While there is still no cure, the new study challenges to show that sTMS does work and prevents migraine attacks.
This study was carried out by a few researchers at Mayo Clinic and other major academic headache centers across the U.S. By this they were able to examine the effectiveness of using a single-pulse transcranial magnetic stimulation device.
Reference
- Amaal J Starling, Stewart J Tepper, Michael J Marmura, Ejaz A Shamim, Matthew S Robbins, Nada Hindiyeh, Andrew C Charles, Peter J Goadsby, Richard B Lipton, Stephen D Silberstein, Amy A Gelfand, Richard P Chiacchierini, David W Dodick. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia, 2018; 033310241876252 DOI: 10.1177/0333102418762525